MedPath
NMPA Approval

Regorafenib Tablets

国药准字HJ20250012

m/s aizant drug research solutions private limited

January 24, 2025

Drug Information

瑞戈非尼片

片剂

40mg

化学药品

January 24, 2025

January 23, 2030

Company Information

Applicant Company

m/s aizant drug research solutions private limited

MFG. BLOCK A & BLOCK B, SY.NO.172/173, APPAREL PARK ROAD, DOOLAPALLY VILLAGE, DUNDIGAL GANDIMAISAMMA MANDAL, MEDCHAL – MALKAJGIRI DISTRICT, PINCODE 500100, TELANGANA STATE, INDIA

Manufacturing Company

m/s aizant drug research solutions private limited

MFG. BLOCK A & BLOCK B, SY.NO.172/173, APPAREL PARK ROAD, DOOLAPALLY VILLAGE, DUNDIGAL GANDIMAISAMMA MANDAL, MEDCHAL – MALKAJGIRI DISTRICT, PINCODE 500100, TELANGANA STATE, INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞戈非尼片 - NMPA 批准文号 | MedPath